LNAI
Lunai Bioworks Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$10.25M
P/E Ratio
—
EPS
$-61.52
Beta
0.33
52W High
$35.97
52W Low
$1.00
50-Day MA
$2.73
200-Day MA
$7.99
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Lunai Bioworks Inc.
Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. The company is headquartered in Los Angeles, California.
Fundamentals
| Revenue (TTM) | 20,940 |
| Gross Profit (TTM) | 20,940 |
| EBITDA | $-9.77M |
| Operating Margin | -6815.00% |
| Return on Equity | -325.50% |
| Return on Assets | -9.65% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $-0.56 |
| Price-to-Book | 0.48 |
| Price-to-Sales (TTM) | 489.28 |
| EV/Revenue | 401.68 |
| EV/EBITDA | -7.37 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $4.53M |
| Float | $3.35M |
| % Insiders | 31.30% |
| % Institutions | 2.73% |
More HEALTHCARE Stocks
Data last updated: 5/25/2026